Skip to main content
Top
Published in: BMC Immunology 1/2009

Open Access 01-12-2009 | Research article

Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo

Authors: Cynthia A Bonville, Caroline M Percopo, Kimberly D Dyer, Jiliang Gao, Calman Prussin, Barbara Foster, Helene F Rosenberg, Joseph B Domachowske

Published in: BMC Immunology | Issue 1/2009

Login to get access

Abstract

Background

We have shown previously that acute infection with the respiratory pathogen, pneumonia virus of mice (PVM), results in local production of the proinflammatory chemokine, CCL3, and that neutrophil recruitment in response to PVM infection is reduced dramatically in CCL3 -/- mice.

Results

In this work, we demonstrate that CCL3-mediated neutrophil recruitment is coordinated by interferon-gamma (IFNγ). Neutrophil recruitment in response to PVM infection was diminished five-fold in IFNγ receptor gene-deleted mice, although neutrophils from IFNγR -/- mice expressed transcripts for the CCL3 receptor, CCR1 and responded functionally to CCL3 ex vivo. Similarly, in the absence of PVM infection, CCL3 overexpression alone could not elicit neutrophil recruitment in the absence of IFNγ. Interestingly, although supplemental IFNγ restored neutrophil recruitment and resulted in a sustained weight loss among CCL3-overexpressing IFNγ -/- mice, CCL3-mediated neutrophil recruitment alone did not result in the pulmonary edema or respiratory failure characteristic of severe viral infection, suggesting that CCL3 and IFN-γ together are sufficient to promote neutrophil recruitment but not pathologic activation.

Conclusion

Our findings reveal a heretofore unrecognized hierarchical interaction between the IFNγ and CCL3, which demonstrate that IFNγ is crucial for CCL3-mediated neutrophil recruitment in vivo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bauer TT, Ewig S, Rodloff AC, Müller E: Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis. 2006, 43: 748-756. 10.1086/506430.CrossRefPubMed Bauer TT, Ewig S, Rodloff AC, Müller E: Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis. 2006, 43: 748-756. 10.1086/506430.CrossRefPubMed
2.
go back to reference Hammer J, Numa A, Newth CJ: Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol. 1997, 23: 176-183. 10.1002/(SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M.CrossRefPubMed Hammer J, Numa A, Newth CJ: Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol. 1997, 23: 176-183. 10.1002/(SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M.CrossRefPubMed
3.
go back to reference Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H, Dong C: Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med. 2006, 174: 1011-1017. 10.1164/rccm.200511-1751OC.CrossRefPubMed Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H, Dong C: Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med. 2006, 174: 1011-1017. 10.1164/rccm.200511-1751OC.CrossRefPubMed
4.
go back to reference Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP: Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005, 68: 4-10.CrossRefPubMed Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP: Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005, 68: 4-10.CrossRefPubMed
5.
go back to reference Salto-Tellez M, Tan E, Lim B: ARDS in SARS: cytokine mediators and treatment implications. Cytokine. 2005, 29: 92-94. 10.1016/j.cyto.2004.09.002.CrossRefPubMed Salto-Tellez M, Tan E, Lim B: ARDS in SARS: cytokine mediators and treatment implications. Cytokine. 2005, 29: 92-94. 10.1016/j.cyto.2004.09.002.CrossRefPubMed
6.
go back to reference Ginsburg HS, Horsfall FL: Characteristics of the multiplication cycle of pneumonia virus of mice (PVM). J Exp Med. 1951, 93: 151-160. 10.1084/jem.93.2.151.CrossRef Ginsburg HS, Horsfall FL: Characteristics of the multiplication cycle of pneumonia virus of mice (PVM). J Exp Med. 1951, 93: 151-160. 10.1084/jem.93.2.151.CrossRef
7.
go back to reference Rosenberg HF, Bonville CA, Easton AJ, Domachowske JB: The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther. 2005, 105: 1-6. 10.1016/j.pharmthera.2004.09.001.CrossRefPubMed Rosenberg HF, Bonville CA, Easton AJ, Domachowske JB: The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther. 2005, 105: 1-6. 10.1016/j.pharmthera.2004.09.001.CrossRefPubMed
8.
go back to reference Easton AJ, Domachowske JB, Rosenberg HF: Pneumonia virus of mice. Perspectives in Medical Virology. Edited by: Cane P. 2006, 12: 299-319. 10.1016/S0168-7069(06)14010-0. Easton AJ, Domachowske JB, Rosenberg HF: Pneumonia virus of mice. Perspectives in Medical Virology. Edited by: Cane P. 2006, 12: 299-319. 10.1016/S0168-7069(06)14010-0.
9.
go back to reference Rosenberg HF, Domachowske JB: Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett. 2008, 118: 6-12. 10.1016/j.imlet.2008.03.013.PubMedCentralCrossRefPubMed Rosenberg HF, Domachowske JB: Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett. 2008, 118: 6-12. 10.1016/j.imlet.2008.03.013.PubMedCentralCrossRefPubMed
10.
go back to reference Bennett NJ, Ellis JA, Bonville CA, Rosenberg HF, Domachowske JB: Immunization strategies for the prevention of pneumovirus infections. Expert Rev Vaccines. 2007, 6: 169-182. 10.1586/14760584.6.2.169.CrossRefPubMed Bennett NJ, Ellis JA, Bonville CA, Rosenberg HF, Domachowske JB: Immunization strategies for the prevention of pneumovirus infections. Expert Rev Vaccines. 2007, 6: 169-182. 10.1586/14760584.6.2.169.CrossRefPubMed
11.
go back to reference Thomas LH, Friedland JS, Sharland M: Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev Anti Infect Ther. 2007, 5: 415-425. 10.1586/14787210.5.3.415.CrossRefPubMed Thomas LH, Friedland JS, Sharland M: Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev Anti Infect Ther. 2007, 5: 415-425. 10.1586/14787210.5.3.415.CrossRefPubMed
12.
go back to reference Bonville CA, Bennett NJ, Koehnlein M, Haines DM, Ellis JA, DelVecchio AM, Rosenberg HF, Domachowske JB: Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology. 2006, 349: 87-95. 10.1016/j.virol.2006.02.017.CrossRefPubMed Bonville CA, Bennett NJ, Koehnlein M, Haines DM, Ellis JA, DelVecchio AM, Rosenberg HF, Domachowske JB: Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology. 2006, 349: 87-95. 10.1016/j.virol.2006.02.017.CrossRefPubMed
13.
go back to reference Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF: The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol. 2000, 165: 2677-2682.CrossRefPubMed Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF: The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol. 2000, 165: 2677-2682.CrossRefPubMed
14.
go back to reference Bonville CA, Easton AJ, Rosenberg HF, Domachowske JB: Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol. 2003, 77: 1237-1244. 10.1128/JVI.77.2.1237-1244.2003.PubMedCentralCrossRefPubMed Bonville CA, Easton AJ, Rosenberg HF, Domachowske JB: Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol. 2003, 77: 1237-1244. 10.1128/JVI.77.2.1237-1244.2003.PubMedCentralCrossRefPubMed
15.
go back to reference Bonville CA, Lau VK, DeLeon JM, Gao JL, Easton AJ, Rosenberg HF, Domachowske JB: Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol. 2004, 78: 7984-7989. 10.1128/JVI.78.15.7984-7989.2004.PubMedCentralCrossRefPubMed Bonville CA, Lau VK, DeLeon JM, Gao JL, Easton AJ, Rosenberg HF, Domachowske JB: Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol. 2004, 78: 7984-7989. 10.1128/JVI.78.15.7984-7989.2004.PubMedCentralCrossRefPubMed
16.
go back to reference Wheelock EF: Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965, 149: 310-311. 10.1126/science.149.3681.310.CrossRef Wheelock EF: Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965, 149: 310-311. 10.1126/science.149.3681.310.CrossRef
17.
go back to reference Pitrez PM, Brennan CS, Sly PD: Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections. Respirology. 2005, 10: 365-370. 10.1111/j.1440-1843.2005.00721.x.CrossRefPubMed Pitrez PM, Brennan CS, Sly PD: Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections. Respirology. 2005, 10: 365-370. 10.1111/j.1440-1843.2005.00721.x.CrossRefPubMed
18.
go back to reference Melendi GA, Laham FR, Monsalvo AC, Casellas JM, Israelí V, Polack NR, Kleeberger SR, Polack FP: Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics. 2007, 120: e410-e415. 10.1542/peds.2006-3283.CrossRefPubMed Melendi GA, Laham FR, Monsalvo AC, Casellas JM, Israelí V, Polack NR, Kleeberger SR, Polack FP: Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics. 2007, 120: e410-e415. 10.1542/peds.2006-3283.CrossRefPubMed
19.
go back to reference Semple MG, Dankert HM, Ebrahimi B, Correia JB, Booth JA, Stewart JP, Smyth RL, Hart GA: Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS ONE. 2007, 2: e1038-10.1371/journal.pone.0001038.PubMedCentralCrossRefPubMed Semple MG, Dankert HM, Ebrahimi B, Correia JB, Booth JA, Stewart JP, Smyth RL, Hart GA: Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS ONE. 2007, 2: e1038-10.1371/journal.pone.0001038.PubMedCentralCrossRefPubMed
20.
go back to reference Renzi PM, Turgeon JP, Marcotte JE, Drblik SP, Berube D, Gagnon MF, Spier S: Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med. 1999, 159: 1417-1422.CrossRefPubMed Renzi PM, Turgeon JP, Marcotte JE, Drblik SP, Berube D, Gagnon MF, Spier S: Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med. 1999, 159: 1417-1422.CrossRefPubMed
21.
go back to reference Aberle JH, Aberle SW, Dworzak MN, Mandl SW, Rebhandl W, Vollnhofer G, Kundi M, Popow-Kraupp T: Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med. 1999, 160: 1263-1268.CrossRefPubMed Aberle JH, Aberle SW, Dworzak MN, Mandl SW, Rebhandl W, Vollnhofer G, Kundi M, Popow-Kraupp T: Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med. 1999, 160: 1263-1268.CrossRefPubMed
22.
go back to reference Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL: Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis. 2001, 184: 355-358. 10.1086/322035.CrossRefPubMed Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL: Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis. 2001, 184: 355-358. 10.1086/322035.CrossRefPubMed
23.
go back to reference Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO: Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003, 168: 633-639. 10.1164/rccm.200210-1148OC.CrossRefPubMed Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO: Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003, 168: 633-639. 10.1164/rccm.200210-1148OC.CrossRefPubMed
24.
go back to reference Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mossmann TR: Human infant respiratory syncytial virus (RSV) – specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis. 2007, 195: 1779-1788. 10.1086/518249.CrossRefPubMed Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mossmann TR: Human infant respiratory syncytial virus (RSV) – specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis. 2007, 195: 1779-1788. 10.1086/518249.CrossRefPubMed
25.
go back to reference Lee YM, Miyahara N, Takeda K, Prpich J, Oh A, Balhorn A, Joetham A, Gelfand EW, Dakhama A: IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med. 2008, 177: 208-218. 10.1164/rccm.200612-1890OC.PubMedCentralCrossRefPubMed Lee YM, Miyahara N, Takeda K, Prpich J, Oh A, Balhorn A, Joetham A, Gelfand EW, Dakhama A: IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med. 2008, 177: 208-218. 10.1164/rccm.200612-1890OC.PubMedCentralCrossRefPubMed
26.
go back to reference Mejías A, Chávez-Bueno S, Ríos AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, Gómez AM, Jafri HS, Ramilo O: Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004, 48: 1811-1822. 10.1128/AAC.48.5.1811-1822.2004.PubMedCentralCrossRefPubMed Mejías A, Chávez-Bueno S, Ríos AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, Gómez AM, Jafri HS, Ramilo O: Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004, 48: 1811-1822. 10.1128/AAC.48.5.1811-1822.2004.PubMedCentralCrossRefPubMed
27.
go back to reference Durbin JE, Durbin RK: Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol. 2004, 17: 370-380. 10.1089/vim.2004.17.370.CrossRefPubMed Durbin JE, Durbin RK: Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol. 2004, 17: 370-380. 10.1089/vim.2004.17.370.CrossRefPubMed
28.
go back to reference Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE: Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol. 2005, 174: 7234-7241.CrossRefPubMed Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE: Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol. 2005, 174: 7234-7241.CrossRefPubMed
29.
go back to reference Claassen EA, Kant van der PA, Rychnavska ZS, van Bleek GM, Easton AJ, Most van der RG: Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol. 2005, 175: 6597-6604.CrossRefPubMed Claassen EA, Kant van der PA, Rychnavska ZS, van Bleek GM, Easton AJ, Most van der RG: Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol. 2005, 175: 6597-6604.CrossRefPubMed
30.
go back to reference Frey S, Krempl CD, Schmitt-Graf A, Ehl S: The role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol. 2008, 82: 11619-11627. 10.1128/JVI.00375-08.PubMedCentralCrossRefPubMed Frey S, Krempl CD, Schmitt-Graf A, Ehl S: The role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol. 2008, 82: 11619-11627. 10.1128/JVI.00375-08.PubMedCentralCrossRefPubMed
31.
go back to reference Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science. 1995, 269: 1583-1585. 10.1126/science.7667639.CrossRefPubMed Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science. 1995, 269: 1583-1585. 10.1126/science.7667639.CrossRefPubMed
32.
go back to reference Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB: The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol. 2000, 165: 6429-6436.CrossRefPubMed Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB: The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol. 2000, 165: 6429-6436.CrossRefPubMed
33.
go back to reference Nys M, Deby-Dupont G, Habraken Y, Legrand-Poels S, Kohnen S, Ledoux D, Canivet JL, Damas P, Lamy Y: Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines. Nitric Oxide. 2003, 9: 33-43. 10.1016/j.niox.2003.07.001.CrossRefPubMed Nys M, Deby-Dupont G, Habraken Y, Legrand-Poels S, Kohnen S, Ledoux D, Canivet JL, Damas P, Lamy Y: Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines. Nitric Oxide. 2003, 9: 33-43. 10.1016/j.niox.2003.07.001.CrossRefPubMed
34.
go back to reference Yang KY, Arcaroli JJ, Abraham E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med. 2003, 167: 1567-1574. 10.1164/rccm.200207-664OC.CrossRefPubMed Yang KY, Arcaroli JJ, Abraham E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med. 2003, 167: 1567-1574. 10.1164/rccm.200207-664OC.CrossRefPubMed
35.
go back to reference Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, Strassheim D, Abraham E: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol. 2002, 72: 571-579.PubMed Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, Strassheim D, Abraham E: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol. 2002, 72: 571-579.PubMed
36.
go back to reference Geerts L, Jorens PG, Willems J, De Ley M, Slegers H: Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med. 2001, 29: 1920-1924. 10.1097/00003246-200110000-00012.CrossRefPubMed Geerts L, Jorens PG, Willems J, De Ley M, Slegers H: Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med. 2001, 29: 1920-1924. 10.1097/00003246-200110000-00012.CrossRefPubMed
37.
go back to reference Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 1998, 76: 91-94. 10.1006/jsre.1998.5295.CrossRefPubMed Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 1998, 76: 91-94. 10.1006/jsre.1998.5295.CrossRefPubMed
38.
go back to reference He M, Horuk R, Bhatia M: Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modifying neutrophil recruitment. Pancreas. 2007, 34: 233-241. 10.1097/mpa.0b013e31802e7598.CrossRefPubMed He M, Horuk R, Bhatia M: Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modifying neutrophil recruitment. Pancreas. 2007, 34: 233-241. 10.1097/mpa.0b013e31802e7598.CrossRefPubMed
39.
go back to reference Anh DB, Faisca P, Desmecht DJ: Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L426-L435. 10.1152/ajplung.00483.2005.CrossRefPubMed Anh DB, Faisca P, Desmecht DJ: Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L426-L435. 10.1152/ajplung.00483.2005.CrossRefPubMed
40.
go back to reference McNamara PS, Flanagan BF, Hart CA, Smyth RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2005, 191: 1225-1232. 10.1086/428855.CrossRefPubMed McNamara PS, Flanagan BF, Hart CA, Smyth RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2005, 191: 1225-1232. 10.1086/428855.CrossRefPubMed
41.
go back to reference Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999, 159: 1918-1924.CrossRefPubMed Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999, 159: 1918-1924.CrossRefPubMed
42.
go back to reference Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY: An interferon-gamma related cytokine storm in SARS patients. J Med Virol. 2005, 75: 185-194. 10.1002/jmv.20255.CrossRefPubMed Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY: An interferon-gamma related cytokine storm in SARS patients. J Med Virol. 2005, 75: 185-194. 10.1002/jmv.20255.CrossRefPubMed
43.
go back to reference Glass WG, Subbarao K, Murphy B, Murphy PM: Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004, 173: 4030-4039.CrossRefPubMed Glass WG, Subbarao K, Murphy B, Murphy PM: Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004, 173: 4030-4039.CrossRefPubMed
44.
go back to reference Yen YT, Liao F, Hsiao CH, Kao CL, Chen YC, Wu-Hsieh BA: Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol. 2006, 80: 2684-2693. 10.1128/JVI.80.6.2684-2693.2006.PubMedCentralCrossRefPubMed Yen YT, Liao F, Hsiao CH, Kao CL, Chen YC, Wu-Hsieh BA: Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol. 2006, 80: 2684-2693. 10.1128/JVI.80.6.2684-2693.2006.PubMedCentralCrossRefPubMed
45.
go back to reference To KF, Chan PKS, Chan KF, Lee WK, Lam WY, Wong KF, Tang NLS, Tsang DNC, Sung RYT, Buckley TA, Tam JS, Cheng AF: Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001, 63: 242-246. 10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N.CrossRefPubMed To KF, Chan PKS, Chan KF, Lee WK, Lam WY, Wong KF, Tang NLS, Tsang DNC, Sung RYT, Buckley TA, Tam JS, Cheng AF: Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001, 63: 242-246. 10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N.CrossRefPubMed
46.
go back to reference Szretter KJ, Gangappa S, Lu X, Smith C, Wun-Ju S, Zaki SR, Sambhara S, Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007, 81: 2736-2744. 10.1128/JVI.02336-06.PubMedCentralCrossRefPubMed Szretter KJ, Gangappa S, Lu X, Smith C, Wun-Ju S, Zaki SR, Sambhara S, Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007, 81: 2736-2744. 10.1128/JVI.02336-06.PubMedCentralCrossRefPubMed
47.
go back to reference Zhou J, Law HKW, Cheung CY, Ng IHY, Peiris JSM, Lau YL: Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis. 2006, 194: 61-70. 10.1086/504690.CrossRefPubMed Zhou J, Law HKW, Cheung CY, Ng IHY, Peiris JSM, Lau YL: Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis. 2006, 194: 61-70. 10.1086/504690.CrossRefPubMed
48.
go back to reference Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med. 1997, 185: 1959-1968. 10.1084/jem.185.11.1959.PubMedCentralCrossRefPubMed Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med. 1997, 185: 1959-1968. 10.1084/jem.185.11.1959.PubMedCentralCrossRefPubMed
49.
50.
go back to reference Hansen BD, Finbloom DS: Characterization of the interaction between recombinant human interferon-γ and its receptor on human polymorphonuclear leukocytes. J Leukoc Biol. 1990, 47: 64-69.PubMed Hansen BD, Finbloom DS: Characterization of the interaction between recombinant human interferon-γ and its receptor on human polymorphonuclear leukocytes. J Leukoc Biol. 1990, 47: 64-69.PubMed
51.
go back to reference Bonecchi R, Polentarutti N, Luini W, Borsatti A, Bernasconi S, Locati M, Power C, Proudfoot A, Wells TN, Mackay C, Mantovani A, Sozzani S: Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-g in human neutrophils. J Immunol. 1999, 162: 474-479.PubMed Bonecchi R, Polentarutti N, Luini W, Borsatti A, Bernasconi S, Locati M, Power C, Proudfoot A, Wells TN, Mackay C, Mantovani A, Sozzani S: Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-g in human neutrophils. J Immunol. 1999, 162: 474-479.PubMed
52.
go back to reference Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, Pearl JE, Ghilardi N, Desauvage FJ, Lund FE, Cooper AM: Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006, 203: 1805-1815. 10.1084/jem.20052545.PubMedCentralCrossRefPubMed Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, Pearl JE, Ghilardi N, Desauvage FJ, Lund FE, Cooper AM: Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006, 203: 1805-1815. 10.1084/jem.20052545.PubMedCentralCrossRefPubMed
53.
go back to reference Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993, 259: 1739-1742. 10.1126/science.8456300.CrossRefPubMed Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993, 259: 1739-1742. 10.1126/science.8456300.CrossRefPubMed
54.
go back to reference Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor. Science. 1993, 259: 1742-1745. 10.1126/science.8456301.CrossRefPubMed Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor. Science. 1993, 259: 1742-1745. 10.1126/science.8456301.CrossRefPubMed
55.
go back to reference Foster B, Prussin C: Unit 6.24, Detection of intracellular cytokines by flow cytometry. Current Protocols in Immunology. Edited by: Coligan JE, Kruisbeek AM, Marguilies DH, Shevach EM, Strober W. 2003, Wiley, 6.24.1-6.24.16. Foster B, Prussin C: Unit 6.24, Detection of intracellular cytokines by flow cytometry. Current Protocols in Immunology. Edited by: Coligan JE, Kruisbeek AM, Marguilies DH, Shevach EM, Strober W. 2003, Wiley, 6.24.1-6.24.16.
56.
go back to reference Gao JL, Guillabert A, Hu J, Le Y, Urizar E, Seligman E, Fang KJ, Yuan X, Imbault V, Communi D, Wang JM, Parmentier M, Murphy PM, Migeotte I: F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. J Immunol. 2007, 178: 1450-1456.CrossRefPubMed Gao JL, Guillabert A, Hu J, Le Y, Urizar E, Seligman E, Fang KJ, Yuan X, Imbault V, Communi D, Wang JM, Parmentier M, Murphy PM, Migeotte I: F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. J Immunol. 2007, 178: 1450-1456.CrossRefPubMed
57.
go back to reference Ellis JA, Martin BV, Waldner C, Dyer KD, Domachowske JB, Rosenberg HF: Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine. 2007, 25: 1085-1095. 10.1016/j.vaccine.2006.09.081.PubMedCentralCrossRefPubMed Ellis JA, Martin BV, Waldner C, Dyer KD, Domachowske JB, Rosenberg HF: Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine. 2007, 25: 1085-1095. 10.1016/j.vaccine.2006.09.081.PubMedCentralCrossRefPubMed
Metadata
Title
Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo
Authors
Cynthia A Bonville
Caroline M Percopo
Kimberly D Dyer
Jiliang Gao
Calman Prussin
Barbara Foster
Helene F Rosenberg
Joseph B Domachowske
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2009
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-10-14

Other articles of this Issue 1/2009

BMC Immunology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.